300015 爱尔眼科
已收盘 11-22 15:00:00
资讯
新帖
简况
爱尔眼科：涉事医院已按要求整改，集团将持续坚持刀刃向内
美港电讯 · 11-20 15:50
爱尔眼科：涉事医院已按要求整改，集团将持续坚持刀刃向内
国家卫健委回复艾芬信访：多家爱尔眼科医院涉嫌出具虚假诊断证明
美港电讯 · 11-19
国家卫健委回复艾芬信访：多家爱尔眼科医院涉嫌出具虚假诊断证明
眼科医院三季报：爱尔眼科持续保持行业龙头地位，光正眼科营收同比降幅最大
财中社 · 11-12
眼科医院三季报：爱尔眼科持续保持行业龙头地位，光正眼科营收同比降幅最大
爱尔眼科（300015）股东陈邦质押5000万股，占总股本0.54%
证券之星 · 11-08
爱尔眼科（300015）股东陈邦质押5000万股，占总股本0.54%
11月7日爱尔眼科涨8.91%，华宝中证医疗ETF基金重仓该股
证券之星 · 11-07
11月7日爱尔眼科涨8.91%，华宝中证医疗ETF基金重仓该股
靴子落地！“喝酒吃药”联袂飙升，医疗ETF（512170）大涨逾3.7%！爱尔眼科、普瑞眼科暴涨超8%
市场资讯 · 11-07
靴子落地！“喝酒吃药”联袂飙升，医疗ETF（512170）大涨逾3.7%！爱尔眼科、普瑞眼科暴涨超8%
华安证券：给予爱尔眼科买入评级
证券之星 · 11-07
华安证券：给予爱尔眼科买入评级
爱尔眼科（300015）641.71万股限售股将于11月6日解禁，占总股本0.07%
证券之星 · 11-06
爱尔眼科（300015）641.71万股限售股将于11月6日解禁，占总股本0.07%
11月5日爱尔眼科涨5.12%，华宝中证医疗ETF基金重仓该股
证券之星 · 11-05
11月5日爱尔眼科涨5.12%，华宝中证医疗ETF基金重仓该股
爱尔眼科涨5.12%，中泰证券一个月前给出“买入”评级
证券之星 · 11-05
爱尔眼科涨5.12%，中泰证券一个月前给出“买入”评级
BRIEF-中国爱尔眼科：逾600万股限售股将于11月6日上市流通
路透中文 · 11-03
BRIEF-中国爱尔眼科：逾600万股限售股将于11月6日上市流通
东吴证券：给予爱尔眼科买入评级
证券之星 · 11-03
东吴证券：给予爱尔眼科买入评级
平安证券：给予爱尔眼科增持评级
证券之星 · 11-01
平安证券：给予爱尔眼科增持评级
爱尔眼科（300015）2024年三季报简析：营收净利润同比双双增长
证券之星 · 11-01
爱尔眼科（300015）2024年三季报简析：营收净利润同比双双增长
国金证券：给予爱尔眼科买入评级
证券之星 · 10-31
国金证券：给予爱尔眼科买入评级
图解爱尔眼科三季报：第三季度单季净利润同比减4.56%
证券之星 · 10-31
图解爱尔眼科三季报：第三季度单季净利润同比减4.56%
爱尔眼科(300015.SZ)发布前三季度业绩，净利润34.52亿元，增长8.50%
智通财经 · 10-30
爱尔眼科(300015.SZ)发布前三季度业绩，净利润34.52亿元，增长8.50%
爱尔眼科最新公告：前三季度净利润34.52亿元 同比增长8.5%
证券之星 · 10-30
爱尔眼科最新公告：前三季度净利润34.52亿元 同比增长8.5%
爱尔眼科：前三季度营收163.02亿元，同比增长1.58%；净利润34.52亿元，同比增长8.5%。
美港电讯 · 10-30
爱尔眼科：前三季度营收163.02亿元，同比增长1.58%；净利润34.52亿元，同比增长8.5%。
字节跳动创始人张一鸣首次问鼎中国首富，马化腾第三、马云第十--胡润
路透中文 · 10-29
字节跳动创始人张一鸣首次问鼎中国首富，马化腾第三、马云第十--胡润
加载更多
公司概况
公司名称：
爱尔眼科医院集团股份有限公司
所属行业：
卫生
上市日期：
2009-10-30
主营业务：
爱尔眼科医院集团股份有限公司是一家眼科医疗机构,公司主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。公司主办了2019国际视网膜高峰论坛、国际屈光论坛、智慧医疗高峰论坛等学术会议，发布《爱尔眼科中国国人眼底病变状况大数据报告》，成功获得2023年第19届世界近视眼大会的主办权。
发行价格：
28.00
{"stockData":{"symbol":"300015","market":"SZ","secType":"STK","nameCN":"爱尔眼科","latestPrice":14.28,"timestamp":1732258998000,"preClose":15.01,"halted":0,"volume":115082165,"delay":0,"floatShares":7911000000,"shares":9327000000,"eps":0.3892,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.73,"latestTime":"11-22 15:00:00","open":14.96,"high":14.99,"low":14.26,"amount":1683000000,"amplitude":0.0486,"askPrice":14.29,"askSize":2327,"bidPrice":14.28,"bidSize":6697,"shortable":0,"etf":0,"ttmEps":0.3892,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1732498200000},"adr":0,"adjPreClose":15.01,"symbolType":"stock","openAndCloseTimeList":[[1732239000000,1732246200000],[1732251600000,1732258800000]],"highLimit":16.51,"lowLimit":13.51,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":9327014495,"pbRate":6.86,"roa":"--","roe":"17.37%","epsLYR":0.3644,"committee":0.348627,"marketValue":133190000000,"floatMarketCap":112975000000,"peRate":36.690647,"changeRate":-0.0486,"turnoverRate":0.0145,"status":1},"requestUrl":"/m/hq/s/300015","defaultTab":"news","newsList":[{"id":"2484016853","title":"爱尔眼科：涉事医院已按要求整改，集团将持续坚持刀刃向内","url":"https://stock-news.laohu8.com/highlight/detail?id=2484016853","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484016853?lang=zh_cn&edition=full","pubTime":"2024-11-20 15:50","pubTimestamp":1732089052,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0028","300015","LU1242518931.SGD","LU1242518857.USD","BK0012","BK0188","BK0236","LU0979878070.USD","BK0077","LU1820825898.SGD","BK0200","BK0114","BK0196","BK0096","BK0113","LU1146622755.USD"],"gpt_icon":0},{"id":"2484944047","title":"国家卫健委回复艾芬信访：多家爱尔眼科医院涉嫌出具虚假诊断证明","url":"https://stock-news.laohu8.com/highlight/detail?id=2484944047","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2484944047?lang=zh_cn&edition=full","pubTime":"2024-11-19 21:51","pubTimestamp":1732024279,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["300015","BK0096","BK0028","BK0236","BK0114","BK0077","BK0113","LU1242518857.USD","LU1146622755.USD","BK0200","LU0979878070.USD","LU1820825898.SGD","LU1242518931.SGD","BK0196","BK0188","BK0012"],"gpt_icon":0},{"id":"2482979728","title":"眼科医院三季报：爱尔眼科持续保持行业龙头地位，光正眼科营收同比降幅最大","url":"https://stock-news.laohu8.com/highlight/detail?id=2482979728","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2482979728?lang=zh_cn&edition=full","pubTime":"2024-11-12 15:02","pubTimestamp":1731394920,"startTime":"0","endTime":"0","summary":" 《财中社》上市公司研究院对5家眼科医院上市公司三季度财务数据进行了整理。总体来看，眼科医院的经营表现参差不齐，市场主要由爱尔眼科主导，其在营收、净利润、ROE等方面均表现突出。 A股医院行业共有15家上市公司，其中有5家属于眼科医院。 从营业收入来看，爱尔眼科持续保持行业龙头地位，2024年前三季度，爱尔眼科一家独大，其次华厦眼科和普瑞眼科属于第二梯队；何氏眼科和光正眼科排在第三梯队。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/roll/2024-11-12/doc-incvutiz1590208.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/roll/2024-11-12/doc-incvutiz1590208.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300015","002524"],"gpt_icon":0},{"id":"2481170439","title":"爱尔眼科（300015）股东陈邦质押5000万股，占总股本0.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481170439","media":"证券之星","labels":["Shareholding Changes"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481170439?lang=zh_cn&edition=full","pubTime":"2024-11-08 21:19","pubTimestamp":1731071988,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科11月8日公开信息显示，股东陈邦向上海海通证券资产管理有限公司合计质押5000.0万股，占总股本0.54%。质押详情见下表：截止本公告日，股东爱尔医疗投资集团有限公司已累计质押股份4.56亿股，占其持股总数的14.23%，股东陈邦已累计质押股份2.56亿股，占其持股总数的17.71%。爱尔眼科主营业务：主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110800041273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"Shareholding Changes","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","LU1242518931.SGD","BK0077","300015","BK0200","LU1146622755.USD","LU1242518857.USD","BK0188","BK0114","BK0236","LU1820825898.SGD","BK0196","BK0012","BK0096","LU0979878070.USD","BK0028"],"gpt_icon":0},{"id":"2481392607","title":"11月7日爱尔眼科涨8.91%，华宝中证医疗ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481392607","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481392607?lang=zh_cn&edition=full","pubTime":"2024-11-07 16:19","pubTimestamp":1730967571,"startTime":"0","endTime":"0","summary":"证券之星消息，11月7日爱尔眼科涨8.91%，收盘报16.5元，换手率4.31%，成交量340.86万手，成交额54.09亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共153家，其中持有数量最多的公募基金为华宝中证医疗ETF。华宝中证医疗ETF目前规模为278.81亿元，最新净值0.3511，较上一交易日下跌0.26%，近一年下跌17.66%。华宝中证医疗ETF的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700026449.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["LU1242518931.SGD","BK0077","512170","BK0096","BK0236","BK0114","LU1820825898.SGD","BK0028","BK0113","LU1242518857.USD","BK0012","159828","BK0188","LU1146622755.USD","300015","BK0196","BK0200","LU0979878070.USD"],"gpt_icon":0},{"id":"2481476789","title":"靴子落地！“喝酒吃药”联袂飙升，医疗ETF（512170）大涨逾3.7%！爱尔眼科、普瑞眼科暴涨超8%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481476789","media":"市场资讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481476789?lang=zh_cn&edition=full","pubTime":"2024-11-07 14:55","pubTimestamp":1730962500,"startTime":"0","endTime":"0","summary":"海外大选靴子落地，11月7日，内需方向强势爆发，“喝酒吃药”久违回归！A股顶流医疗ETF全天持续走高，午后继续上攻，尾盘上探3.7%，实时成交额近10亿元！ 成份股方面，与消费关联度较高的民营医院概念领涨，新里程涨超10%，普瑞眼科、爱尔眼科涨超7%！“医美龙头”爱美客涨超6%，“牙茅”通策医疗涨超5%。 消息面，美国大选结果基本落地，特朗普成功逆袭当选美国新一任总统。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/money/fund/etf/2024-11-07/doc-incvfpyx2321404.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/money/fund/etf/2024-11-07/doc-incvfpyx2321404.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["300015","BK0200","BK0077","LU1242518857.USD","159828","301239","LU0979878070.USD","512170","BK0188","BK0114","LU1820825898.SGD","BK0113","LU1146622755.USD","BK0012","BK0236","BK0196","BK0096","BK0028","LU1242518931.SGD"],"gpt_icon":0},{"id":"2481911212","title":"华安证券：给予爱尔眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481911212","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481911212?lang=zh_cn&edition=full","pubTime":"2024-11-07 12:04","pubTimestamp":1730952279,"startTime":"0","endTime":"0","summary":"华安证券股份有限公司谭国超,陈珈蔚近期对爱尔眼科进行研究并发布了研究报告《业绩略承压，经营韧性依旧》，本报告对爱尔眼科给出买入评级，当前股价为15.77元。 投资建议 预计公司2024~2026年将实现营业收入223.11/247.64/279.71亿元，同比+9.5%/11.0%/13.0%；实现归母净利润38.08/43.93/51.49亿元，同比+13.4%/15.4%/17.2%，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有22家机构给出评级，买入评级18家，增持评级4家；过去90天内机构目标均价为15.21。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110700018108.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600909","300015"],"gpt_icon":0},{"id":"2481664913","title":"爱尔眼科（300015）641.71万股限售股将于11月6日解禁，占总股本0.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2481664913","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481664913?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:04","pubTimestamp":1730851496,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，爱尔眼科于11月6日将有641.71万股限售股份解禁，为公司股权激励限售股份，占公司总股本0.07%。最近一年内，该股累计解禁2037.87万股，占总股本的0.22%。本次解禁后，公司还有14.16亿股限售股份，占总股本15.18%。爱尔眼科主营业务：主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0113","LU1242518931.SGD","BK0077","300015","BK0200","LU1146622755.USD","LU1242518857.USD","BK0188","BK0114","BK0236","LU1820825898.SGD","BK0196","BK0012","BK0096","LU0979878070.USD","BK0028"],"gpt_icon":0},{"id":"2481255775","title":"11月5日爱尔眼科涨5.12%，华宝中证医疗ETF基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2481255775","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481255775?lang=zh_cn&edition=full","pubTime":"2024-11-05 16:20","pubTimestamp":1730794843,"startTime":"0","endTime":"0","summary":"证券之星消息，11月5日爱尔眼科涨5.12%，收盘报15.2元，换手率3.13%，成交量247.45万手，成交额37.22亿元。根据2024基金Q3季报公募基金重仓股数据，重仓该股的公募基金共153家，其中持有数量最多的公募基金为华宝中证医疗ETF。华宝中证医疗ETF目前规模为278.81亿元，最新净值0.3416，较上一交易日上涨1.33%，近一年下跌17.63%。华宝中证医疗ETF的前十大重仓股如下：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500026126.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0236","LU1146622755.USD","LU1242518931.SGD","BK0077","159828","BK0114","BK0113","BK0012","BK0028","BK0196","300015","BK0188","LU0979878070.USD","LU1242518857.USD","LU1820825898.SGD","512170","BK0200","BK0096"],"gpt_icon":0},{"id":"2481255755","title":"爱尔眼科涨5.12%，中泰证券一个月前给出“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2481255755","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481255755?lang=zh_cn&edition=full","pubTime":"2024-11-05 16:20","pubTimestamp":1730794835,"startTime":"0","endTime":"0","summary":"今日爱尔眼科（300015）涨5.12%，收盘报15.2元。2024年9月9日，中泰证券研究员祝嘉琦,孙宇瑶发布了对爱尔眼科的研报《经营保持韧性，体外医院收购稳步推进》，该研报对爱尔眼科给出“买入”评级。证券之星数据中心根据近三年发布的研报数据计算，该研报作者对此股的盈利预测准确度为84.57%。此外，国投证券研究员马帅,贺鑫，东吴证券研究员朱国广,冉胜男,苏丰近期也对该股发布了研报，同样给出“买入”评级。证券之星数据中心计算显示，对该股盈利预测较准的分析师团队为中金公司的张琎。爱尔眼科（300015）个股概况：以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500026120.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["600918","300015"],"gpt_icon":0},{"id":"2480361182","title":"BRIEF-中国爱尔眼科：逾600万股限售股将于11月6日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2480361182","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480361182?lang=zh_cn&edition=full","pubTime":"2024-11-03 21:59","pubTimestamp":1730642379,"startTime":"0","endTime":"0","summary":"BRIEF-中国爱尔眼科：逾600万股限售股将于11月6日上市流通路透北京11月3日 - 中国爱尔眼科300015.SZ：* 6,417,119限售股将于11月6日上市流通，占公司目前总股本的 0.0688%（完）公告全文，请点击此处 (发稿 刘珞焱) ((luoyan.liu@tr.com))","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241103:nL4T3MA02Y:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0077","LU1146622755.USD","LU1242518857.USD","LU1820825898.SGD","BK0196","LU0979878070.USD","BK0188","BK0028","BK0114","BK0200","BK0236","300015","BK0113","LU1242518931.SGD","BK0012"],"gpt_icon":0},{"id":"2480366184","title":"东吴证券：给予爱尔眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480366184","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480366184?lang=zh_cn&edition=full","pubTime":"2024-11-03 20:56","pubTimestamp":1730638582,"startTime":"0","endTime":"0","summary":"东吴证券股份有限公司朱国广,冉胜男,苏丰近期对爱尔眼科进行研究并发布了研究报告《2024年三季报点评：业绩略承压，外延并购战略持续推进》，本报告对爱尔眼科给出买入评级，当前股价为14.18元。公司新院爬坡后有望贡献利润，大环境复苏后消费眼科恢复预期强、增长弹性大，维持“买入”评级。最新盈利预测明细如下：该股最近90天内共有21家机构给出评级，买入评级17家，增持评级4家；过去90天内机构目标均价为13.58。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110300001815.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","601555"],"gpt_icon":0},{"id":"2480004432","title":"平安证券：给予爱尔眼科增持评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2480004432","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480004432?lang=zh_cn&edition=full","pubTime":"2024-11-01 12:10","pubTimestamp":1730434232,"startTime":"0","endTime":"0","summary":"平安证券股份有限公司叶寅,倪亦道,王钰畅近期对爱尔眼科进行研究并发布了研究报告《具备经营韧性，静待消费复苏》，本报告对爱尔眼科给出增持评级，当前股价为14.39元。 维持“推荐”评级。最新盈利预测明细如下：该股最近90天内共有20家机构给出评级，买入评级17家，增持评级3家；过去90天内机构目标均价为13.58。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100020175.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015","161027"],"gpt_icon":0},{"id":"2480099785","title":"爱尔眼科（300015）2024年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2480099785","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2480099785?lang=zh_cn&edition=full","pubTime":"2024-11-01 06:48","pubTimestamp":1730414926,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期爱尔眼科发布2024年三季报。根据财报显示，爱尔眼科营收净利润同比双双增长。截至本报告期末，公司营业总收入163.02亿元，同比上升1.58%，归母净利润34.52亿元，同比上升8.5%。持有爱尔眼科最多的基金为华宝中证医疗ETF，目前规模为278.81亿元，最新净值0.3414，较上一交易日下跌0.23%，近一年下跌18.19%。以欧洲子公司 Clínica Baviera 为例，自 2017 年收购后，截至 2023 年底，实现营业收入超 15%、净利润超 25%的年复合增长，显著超过收购之前的增速。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110100007709.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015"],"gpt_icon":0},{"id":"2479260726","title":"国金证券：给予爱尔眼科买入评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2479260726","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479260726?lang=zh_cn&edition=full","pubTime":"2024-10-31 14:40","pubTimestamp":1730356854,"startTime":"0","endTime":"0","summary":"国金证券股份有限公司袁维近期对爱尔眼科进行研究并发布了研究报告《业绩具备韧性，看好公司长期发展》，本报告对爱尔眼科给出买入评级，当前股价为14.5元。与此同时，爱尔眼科已在全国成立近50家儿童干眼门诊，并设立干眼合作示范中心，为干眼儿童提供一站式干眼诊疗方案。最新盈利预测明细如下：该股最近90天内共有20家机构给出评级，买入评级17家，增持评级3家；过去90天内机构目标均价为13.58。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100023989.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015"],"gpt_icon":0},{"id":"2479773783","title":"图解爱尔眼科三季报：第三季度单季净利润同比减4.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479773783","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479773783?lang=zh_cn&edition=full","pubTime":"2024-10-31 01:16","pubTimestamp":1730308603,"startTime":"0","endTime":"0","summary":"证券之星消息，爱尔眼科2024年三季报显示，公司主营收入163.02亿元，同比上升1.58%；归母净利润34.52亿元，同比上升8.5%；扣非净利润31.13亿元，同比上升0.26%；其中2024年第三季度，公司单季度主营收入57.56亿元，同比下降0.68%；单季度归母净利润14.02亿元，同比下降4.56%；单季度扣非净利润13.28亿元，同比下降1.34%；负债率34.69%，投资收益1.49亿元，财务费用1.41亿元，毛利率51.02%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103100002279.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015"],"gpt_icon":0},{"id":"2479201873","title":"爱尔眼科(300015.SZ)发布前三季度业绩，净利润34.52亿元，增长8.50%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479201873","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479201873?lang=zh_cn&edition=full","pubTime":"2024-10-30 20:14","pubTimestamp":1730290481,"startTime":"0","endTime":"0","summary":"智通财经APP讯，爱尔眼科(300015.SZ)发布2024年三季度报告，该公司前三季度营业收入为163.02亿元，同比增长1.58%。归属于上市公司股东的净利润为34.52亿元，同比增长8.50%。归属于上市公司股东的扣除非经常性损益的净利润为31.13亿元，同比增长0.26%。基本每股收益为0.3746元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1204061.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["300015"],"gpt_icon":0},{"id":"2479820855","title":"爱尔眼科最新公告：前三季度净利润34.52亿元 同比增长8.5%","url":"https://stock-news.laohu8.com/highlight/detail?id=2479820855","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479820855?lang=zh_cn&edition=full","pubTime":"2024-10-30 19:11","pubTimestamp":1730286677,"startTime":"0","endTime":"0","summary":"爱尔眼科发布2024年第三季度报告，前三季度实现营业收入163.02亿元，同比增长1.58%；归属于上市公司股东的净利润34.52亿元，同比增长8.50%；基本每股收益0.3746元。第三季度实现营业收入57.56亿元，同比下降0.68%；归属于上市公司股东的净利润14.02亿元，同比下降4.56%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000036983.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300015"],"gpt_icon":0},{"id":"2479270648","title":"爱尔眼科：前三季度营收163.02亿元，同比增长1.58%；净利润34.52亿元，同比增长8.5%。","url":"https://stock-news.laohu8.com/highlight/detail?id=2479270648","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479270648?lang=zh_cn&edition=full","pubTime":"2024-10-30 19:02","pubTimestamp":1730286126,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["BK0196","LU0979878070.USD","BK0236","LU1146622755.USD","BK0012","LU1820825898.SGD","300015","BK0096","BK0188","BK0200","BK0028","BK0113","BK0077","BK0114","LU1242518857.USD","LU1242518931.SGD"],"gpt_icon":0},{"id":"2479449112","title":"字节跳动创始人张一鸣首次问鼎中国首富，马化腾第三、马云第十--胡润","url":"https://stock-news.laohu8.com/highlight/detail?id=2479449112","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479449112?lang=zh_cn&edition=full","pubTime":"2024-10-29 14:04","pubTimestamp":1730181859,"startTime":"0","endTime":"0","summary":"路透北京10月29日 - 胡润研究院周二发布2024年百富榜显示，字节跳动创始人张一鸣以3,500亿元人民币的财富规模第一次成为中国首富；农夫山泉9633.HK创始人钟睒睒在连拿三年首富桂冠后，今年跌至第二。其中，41岁的张一鸣财富比去年增长1,050亿元，以3,500亿元第一次成为中国首富，他是过去26年来第18位中国首富，也是第一位“80后”白手起家的中国首富。娃哈哈接班人42岁的宗馥莉取代邝肖卿成为中国女首富，财富810亿元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241029:nL4S3M50NZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["89988","LU0072462343.USD","LU0072913022.USD","LU1515016050.SGD","EVS.SI","LU0228659784.USD","09633","BK1575","LU0132412106.USD","LU1267930227.SGD","LU0128522157.USD","LU0320764755.SGD","BK4554","LU0084288322.USD","IE0008368411.USD","LU0029875118.USD","IE00BD6J9T35.USD","BK4502","LU1152091754.HKD","BABA","300015","LU0572944931.SGD","LU1688375341.USD","IE00BZ08YR35.GBP","09988","LU0455707207.USD","00700","BK4220","BK1526","80700","LU0173614495.USD","300750","LU0196878994.USD","IE0003795394.USD","LU0405327494.USD","LU0061477393.USD","LU0229945570.USD","LU0140636845.USD","LU0163747925.USD","LU1064130708.USD","IE00B067MR52.USD","LU1146622755.USD","LU0107464264.USD","IE00BF5LJ272.USD","LU0463099449.HKD","LU0211977185.USD","LU0127658192.USD","HK0000306685.HKD","LU0130103400.USD","LU0080751232.USD"],"gpt_icon":1}],"profile":{"ret":0,"listingDate":"2009-10-30","address":"湖南省长沙市天心区芙蓉南路一段188号爱尔大厦","stockEarnings":[{"period":"1week","weight":-0.0537},{"period":"1month","weight":-0.0338},{"period":"3month","weight":0.4337},{"period":"6month","weight":0.1783},{"period":"1year","weight":-0.1667},{"period":"ytd","weight":-0.0861}],"companyName":"爱尔眼科医院集团股份有限公司","boardCode":"AI0083","perCapita":"21222股","boardName":"卫生","registeredCapital":"932701万元","compareEarnings":[{"period":"1week","weight":-0.0191},{"period":"1month","weight":-0.0108},{"period":"3month","weight":0.1446},{"period":"6month","weight":0.0577},{"period":"1year","weight":0.0671},{"period":"ytd","weight":0.0982}],"survey":" 爱尔眼科医院集团股份有限公司是一家眼科医疗机构,公司主要从事各类眼科疾病诊疗、手术服务与医学验光配镜。公司主办了2019国际视网膜高峰论坛、国际屈光论坛、智慧医疗高峰论坛等学术会议，发布《爱尔眼科中国国人眼底病变状况大数据报告》，成功获得2023年第19届世界近视眼大会的主办权。","serverTime":1732297693720,"listedPrice":28,"stockholders":"372778人(较上一季度增加5.46%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"爱尔眼科,300015,爱尔眼科股票,爱尔眼科股票老虎,爱尔眼科股票老虎国际,爱尔眼科行情,爱尔眼科股票行情,爱尔眼科股价,爱尔眼科股市,爱尔眼科股票价格,爱尔眼科股票交易,爱尔眼科股票购买,爱尔眼科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"爱尔眼科(300015)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供爱尔眼科(300015)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}